LDE225

A drug used to treat locally advanced basal cell carcinoma (BCC) that has come back after surgery or radiation therapy. It is also used in patients who cannot be treated with surgery or radiation therapy. LDE225 is also being studied in the treatment of other types of cancer. LDE225 blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells. It is a type of hedgehog signaling pathway antagonist. Also called erismodegib, Odomzo, and sonidegib. (NCI Dictionary)

YOU MAY ALSO LIKE

LDB2 wt Allele

Human LDB2 wild-type allele is located in the vicinity of 4p16 and is approximately 397 kb in length. This allele, which encodes…

LDB2 Gene

This gene is involved in the regulation of transcription.

LDB1 wt Allele

Human LDB1 wild-type allele is located within 10q24-q25 and is approximately 13 kb in length. This allele, which encodes LIM domain-binding protein…

LDB1 Gene

This gene is involved in the modulation of transcription.

LD-50

The dose of a chemical or biologic preparation (e.g., a bacterial exotoxin or a suspension of bacteria) that is likely to cause…

LCP2 wt Allele

Human LCP2 wild-type allele is located within 5q33.1-qter and is approximately 50 kb in length. This allele, which encodes lymphocyte cytosolic protein…